1. Completed
Loading page
SME
SME issue. Listed.
Source: IPO Guru Pro
Company information, issue size, price band, lot size, minimum investment, and the dates published for this issue.
Goldline Pharmaceutical Limited was established in 2005 and is engaged in the marketing and distribution of pharmaceutical formulations across India. The company has built its presence through a wide portfolio of healthcare products catering to multiple therapeutic segments. Over the years, Goldline has expanded its distribution network and strengthened relationships with doctors, distributors, and healthcare professionals. The company is promoted by experienced industry professionals who focus on expanding the brand presence and improving market reach in the domestic pharmaceutical sector. The company offers products across general medicine, antibiotics, cardiology, diabetology, gynecology, pediatrics, and wellness categories. Goldline Pharmaceutical mainly follows an asset-light business model, where manufacturing is outsourced to third-party pharma manufacturers while the company focuses on branding, marketing, and distribution activities. This model helps reduce capital expenditure and improve scalability. The company’s operations are mainly based in Nagpur, Maharashtra, with a growing presence across multiple Indian states through its marketing and sales network.
Current premium in rupees, the derived percentage, and the indicative price. History shows observed readings only. A missing premium is unavailable, not ₹0.
Grey Market Premium (GMP) is an unofficial market indicator and is not published by stock exchanges. Estimated listing values are illustrative, may change, and should not be considered a forecast or investment recommendation.
Indicative only. A GMP-implied price is not a guaranteed listing price.
Subscription is shown in times subscribed. A missing multiple stays unavailable. A published zero is 0x.
Last updated: Unavailable
Last updated: Unavailable
Source: IPO Guru Pro Data by IPO Guru
History retrieved: 05 Nov 2026, 5:45 PM IST
No day-wise subscription history is loaded. Missing days are left blank and are not plotted as zero.
Source: IPO Guru Pro. History retrieved 05 Nov 2026, 5:45 PM IST.
Revenue and profit are in rupees for each reporting period. Assets, liabilities, and ratios use the source unit when the statement includes them. Missing figures stay blank.
| Metric (Rs. Crore) | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 27.40 | 26.28 | 22.93 | 19.39 |
| Total Income | 21.41 | 28.06 | 23.57 | 19.85 |
| Profit After Tax | 2.22 | 2.83 |
Results may still be pending. Check Allotment opens the registrar allotment portal. You may need to select this IPO there. Sign-in is not required.
This is the actual change from the issue price to the listing price. It is separate from the unofficial GMP estimate. A missing price stays unavailable.
RHP, DRHP, and other links that passed the official address check. Unverified addresses are left out.
DRHP, RHP and other source documents appear here when the issue includes them.
Data by IPO Guru · Updated
Goldline Pharmaceutical IPO will open from 12 May 2026 to 14 May 2026. Established in 2005, the company is engaged in marketing pharmaceutical products under its “Goldline” brand across segments like general medicine, cardiology, diabetology, pediatrics, and wellness. The company follows an asset-light business model by outsourcing manufacturing to third-party pharma manufacturers while focusing on branding and distribution. Goldline has a strong presence across multiple Indian states, with operations mainly based in Nagpur, Maharashtra.
Amol Laxmikant Mujumdar and Swapan Premprakash Khandelwal
1. Completed
2. Completed
3. Completed
4. Completed
Refund
Demat credit
Unofficial grey-market premium in rupees. Missing observations are not connected and are not drawn as ₹0. This chart is not the listing gain.
High unavailable · Low unavailable
Tap a point for its rupee amount, percentage, and IST time. The table lists the same observations.
Source: IPO Guru Pro. History retrieved 05 Nov 2026, 5:45 PM IST.
| Observed (IST) | GMP (₹) | GMP % | Mark |
|---|---|---|---|
| 18 May 2026, 5:31 PM IST | ₹15 | +34.88% | None |
No intraday GMP history is loaded. Missing slots are not filled in.
High unavailable · Low unavailable
Source: IPO Guru Pro. History retrieved 05 Nov 2026, 5:45 PM IST.
| 1.81 |
| 0.26 |
| EBITDA | 4.16 | 5.83 | 4.30 | 2.19 |
| NET Worth | 12.36 | 10.35 | 7.86 | 5.89 |
| Reserves and Surplus | 3.65 | 1.65 | 3.76 | 2.08 |
| Total Borrowing | 9.47 | 11.03 | 11.13 | 10.83 |